Recent Work for Life Sciences
Series C Investment by MVM Partners LLP and Sofinnova Partners SAS in Neurent Medical Limited
17/FEB/2026Byrne Wallace Shields LLP is pleased to have acted for MVM Partners LLP and Sofinnova Partners SAS i..
PrioThera Series B Investment
03/FEB/2026Byrne Wallace Shields LLP is pleased to have acted for our client, biotech company, PrioThera in rel..
Neuromod Devices Limited
13/APR/2023Byrne Wallace Shields LLP advises Neuromod Devices Limited...
European Circular Bioeconomy Fund
04/JAN/2022Byrne Wallace Shields LLP advises the European Circular Bioeconomy Fund (ECBF)...
